학술논문
Comparison of the safety and persistence of immunogenicity of bivalent HPV16/18 vaccine in healthy 9–14-year-old and 18–26-year-old Chinese females: A randomized, double-blind, non-inferiority clinical trial
Document Type
Article
Author
Source
In Vaccine 22 November 2023 41(48):7212-7219
Subject
Language
ISSN
0264-410X